|
An Ophthalmic Safety Study in Patients With Breast Cancer
RECRUITINGSponsored by AstraZeneca
Actively Recruiting
SponsorAstraZeneca
Started2025-03-04
Est. completion2027-07-06
Eligibility
Age18 Years – 130 Years
Healthy vol.Accepted
Locations12 sites
View on ClinicalTrials.gov →
NCT06767462
Summary
To assess ophthalmic health in parallel cohorts of patients with breast cancer
Eligibility
Age: 18 Years – 130 YearsHealthy volunteers accepted
Inclusion Criteria: 1. Signed informed consent in the qualifying study. 2. Signed informed consent in the ophthalmic study prior to any ophthalmic study specific assessments and procedures. 3. Completed the baseline ophthalmic examination for this study before the first dose in the qualifying study. 4. Meets all the eligibility criteria in the qualifying study Exclusion Criteria: 1. Patients not randomized and not receiving study assigned treatment in a qualifying study. 2. Patients with contraindications to any ophthalmic procedure required by the study or sensitivity/allergy to pupil dilating agents. 3. Judgement by the investigator that the patient should not participate in the ophthalmic study if the patient is unlikely to comply with study procedures, restrictions, and requirements
Conditions3
Breast CancerCancerOphthalmic Safety in Patients With Breast Cancer
Locations12 sites
Research Site
Research Site
Research Site
Research Site
Iowa City, Iowa, 52242
Find trials near these locations
Cancer trials in San DiegoCancer trials in New YorkCancer trials in ClevelandCancer trials in HoustonBreast Cancer trials in San DiegoBreast Cancer trials in New YorkBreast Cancer trials in ClevelandBreast Cancer trials in HoustonAll trials in CaliforniaAll trials in New YorkAll trials in North CarolinaAll trials in OhioAll trials in PennsylvaniaAll trials in TennesseeAll trials in Texas
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorAstraZeneca
Started2025-03-04
Est. completion2027-07-06
Eligibility
Age18 Years – 130 Years
Healthy vol.Accepted
Locations12 sites
View on ClinicalTrials.gov →
NCT06767462